Search This Blog

Thursday, May 23, 2013

McKesson's InterQual 2013 Deepens McKesson's Commitment to Supporting High-Quality, Efficient Care

McKesson News Release:

McKesson's InterQual 2013 Deepens McKesson's Commitment to Supporting High-Quality, Efficient Care
May 22, 2013

Expanded Content and Intelligent Workflows Help Improve Accessibility and Impact

NEWTON, Mass., May 22, 2013 — McKesson has released the 2013 update of its InterQual® clinical content and software portfolio, market-leading solutions that help payers and providers determine the use of the right healthcare resources at the right time to help improve the quality of care. Enhancements this year not only expand the breadth of conditions that the evidence-based criteria cover but also provide intelligent workflows that facilitate interaction with the content. With more interactive, actionable content, payers and providers can more easily collaborate in decisions about medical appropriateness.
“With each release, we aim to not only deepen our content portfolio but also make that content more actionable through a variety of format and technology enhancements,” said A. Jacqueline Mitus, MD, senior vice president, Clinical Development and Strategy, at McKesson Health Solutions. “Rendering clinical content more accessible and interactive helps bring greater consistency, collaboration, efficiency and quality to both the delivery of healthcare services and the business of healthcare.”
McKesson’s Decision Management solutions provide a shared language to help payers, providers and other organizations determine the evidence-based clinical appropriateness of settings of care, diagnostic and therapeutic interventions, surgical procedures and behavioral health services. Organizations then have a wide variety of technology options to bring the criteria directly to the point of care, helping decrease administrative costs and improve clinical decision-making. InterQual solutions are used by more than 300 managed care organizations and 4,100 provider organizations and leading government entities, representing 86% of all U.S. hospital discharges and 95% of all reasons for admissions, procedures and imaging studies. In addition, InterQual is licensed by 95% of the 100 Top Hospitals in the United States, as named by the Truven Health 100 Top Hospitals®program.
“As healthcare transforms and focuses on value, embedding this intelligent content into interactive workflows will be critical. Actionable intelligence facilitates transparency between payers and providers, resulting in improved collaboration and partnership,” said Matthew Zubiller, vice president, Decision Management, at McKesson Health Solutions.
Notable enhancements in InterQual 2013 include the following:
  • InterQual Procedures Criteria and InterQual Imaging Criteria now employ an intuitive format in which the criteria are presented in a series of simple, rules-driven questions. Where appropriate, the best evidence-based recommendation is made based on the clinical scenario presented, driving more value from criteria use. The Procedures Criteria include six new subsets (e.g., for scoliosis surgery), and four Imaging Criteria subsets now include the adolescent age group (13 to 17 year-olds).
  • InterQual Acute Criteria include ten new adult and 12 new pediatric “condition-specific” subsets as well as enhanced extended-stay criteria. The condition-specific model presents criteria for all levels of care in one workflow, combines severity and intensity criteria for admission and continued-stay review, and incorporates unique “response to treatment” components, all of which help streamline the content, improve navigation and enhance payer-provider collaboration.
  • CriteriaView™ is a new feature in CareEnhance® Review Manager Enterprise, browser-based, interactive software that provides access to InterQual Criteria and helps automate and streamline the care review process. CriteriaView gives primary reviewers the ability to see all possible recommendations as they navigate down the criteria algorithm in the question-and-answer model. This approach helps reviewers understand which criteria are not met for medical necessity and at which point in the decision-making process a certain procedure, imaging study or service stopped being an option. CriteriaView also allows organizations to view all of the criteria associated with a procedure, imaging study or service.
  • Continuing its commitment to helping physicians and health plans provide the best cancer treatment options, and leveraging its partnership with the National Comprehensive Cancer Network® (NCCN®), McKesson extended the InterQual Specialty Rx Oncology Criteria to include an additional 13 oncology drugs. In addition, the InterQual Specialty Rx Non-Oncology Criteria now include eight new non-oncology drugs.
  • McKesson also expanded its market-leading InterQual Molecular Diagnostic Criteria to provide evidence-based decision support for 97 new tests, bringing the total number of molecular and genetic tests to 661.
For more information on McKesson Health Solutions, please visit our Web site, hear from our experts at MHSDialogue and follow us on Twitter at @McKesson_MHS.
Related McKesson Health Solutions News 
About McKesson Corporation
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit us at www.mckesson.com.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.